A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma

被引:9
|
作者
Li, Wencui [1 ]
Shen, Hongru [2 ]
Han, Lizhu [1 ]
Liu, Jiaxin [1 ]
Xiao, Bohan [1 ]
Li, Xubin [1 ]
Ye, Zhaoxiang [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Liver Canc Ctr, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc,Dept Radiol,Key Lab Can, Tianjin, Peoples R China
[2] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Tianjin Canc Inst,Natl Clin Res Ctr Canc, Tianjin, Peoples R China
基金
芬兰科学院; 美国国家科学基金会;
关键词
SURVIVAL; HEPATECTOMY; RESECTION; INVASION;
D O I
10.1155/2022/3704987
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The postoperative early recurrence (ER) rate of hepatocellular carcinoma (HCC) is 50%, and no highly reliable predictive tool has been developed yet. The aim of this study was to develop and validate a predictive model with radiomics analysis based on multiparametric magnetic resonance (MR) images to predict early recurrence of HCC. Methods. In total, 302 patients (training dataset: n = 211; validation dataset: n = 91) with pathologically confirmed HCC who underwent preoperative MR imaging were enrolled in this study. Three-dimensional regions of interest of the entire lesion were accessed by manually drawing along the tumor margins on the multiple sequences of MR images. Least absolute shrinkage and selection operator Cox regression were then applied to select ER-related radiomics features and construct radiomics signatures. Univariate analysis and multivariate Cox regression analysis were used to identify the significant clinico-radiological factors and establish a clinico-radiological model. A predictive model of ER incorporating the fusion radiomics signature and clinico-radiological risk factors was constructed. The diagnostic performance and clinical utility of this model were measured by receiver-operating characteristic (ROC), calibration curve, and decision curve analyses. Results. The fusion radiomics signature consisting of 6 radiomics features achieved good prediction performance (training dataset: AUC = 0.85, validation dataset: AUC = 0.79). The predictive model of ER integrating clinico-radiological risk factors and the fusion radiomics signature improved the prediction efficacy with AUCs of 0.91 and 0.87 in the training and validation datasets, respectively. Furthermore, the nomogram and ER risk stratification system based on the predictive model demonstrated encouraging predictions of the individualized risk of ER and gave three risk groups with low, intermediate, or high risk of ER. Conclusions. The proposed predictive model incorporating clinico-radiological factors and the fusion radiomics signature derived from multiparametric MR images may be an effective tool for the individualized prediction of postoperative ER in patients with HCC.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] MRI radiomics based on deep learning automated segmentation to predict early recurrence of hepatocellular carcinoma
    Wei, Hong
    Zheng, Tianying
    Zhang, Xiaolan
    Wu, Yuanan
    Chen, Yidi
    Zheng, Chao
    Jiang, Difei
    Wu, Botong
    Guo, Hua
    Jiang, Hanyu
    Song, Bin
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [42] Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm
    Ruiying Zheng
    Xiaoer Zhang
    Baoxian Liu
    Yi Zhang
    Hui Shen
    Xiaoyan Xie
    Shurong Li
    Guangliang Huang
    European Radiology, 2023, 33 : 6462 - 6472
  • [43] Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm
    Zheng, Ruiying
    Zhang, Xiaoer
    Liu, Baoxian
    Zhang, Yi
    Shen, Hui
    Xie, Xiaoyan
    Li, Shurong
    Huang, Guangliang
    EUROPEAN RADIOLOGY, 2023, 33 (09) : 6462 - 6472
  • [44] Deep learning model based on contrast-enhanced MRI for predicting post-surgical survival in patients with hepatocellular carcinoma
    Ma, Lidi
    Li, Congrui
    Li, Haixia
    Zhang, Cheng
    Deng, Kan
    Zhang, Weijing
    Xie, Chuanmiao
    HELIYON, 2024, 10 (11)
  • [45] Automatic segmentation of hepatocellular carcinoma on dynamic contrast-enhanced MRI based on deep learning
    Luo, Xiao
    Li, Peiwen
    Chen, Hongyi
    Zhou, Kun
    Piao, Sirong
    Yang, Liqin
    Hu, Bin
    Geng, Daoying
    PHYSICS IN MEDICINE AND BIOLOGY, 2024, 69 (06):
  • [46] CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma
    Ying Zhou
    Lan He
    Yanqi Huang
    Shuting Chen
    Penqi Wu
    Weitao Ye
    Zaiyi Liu
    Changhong Liang
    Abdominal Radiology, 2017, 42 : 1695 - 1704
  • [47] Radiomics model of contrast-enhanced MRI for early prediction of acute pancreatitis severity
    Lin, Qiao
    Ji, Yi-fan
    Chen, Yong
    Sun, Huan
    Yang, Dan-dan
    Chen, Ai-li
    Chen, Tian-wu
    Zhang, Xiao Ming
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 51 (02) : 397 - 406
  • [48] CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma
    Zhou, Ying
    He, Lan
    Huang, Yanqi
    Chen, Shuting
    Wu, Penqi
    Ye, Weitao
    Liu, Zaiyi
    Liang, Changhong
    ABDOMINAL RADIOLOGY, 2017, 42 (06) : 1695 - 1704
  • [49] Radiomics Based on Contrast-Enhanced MRI in Differentiation Between Fat-Poor Angiomyolipoma and Hepatocellular Carcinoma in Noncirrhotic Liver: A Multicenter Analysis
    Zhao, Xiangtian
    Zhou, Yukun
    Zhang, Yuan
    Han, Lujun
    Mao, Li
    Yu, Yizhou
    Li, Xiuli
    Zeng, Mengsu
    Wang, Mingliang
    Liu, Zaiyi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI
    Zongren Ding
    Yijun Wu
    Guoxu Fang
    Zhaowang Lin
    Kongying Lin
    Jun Fu
    Qizhen Huang
    Yanyan Tang
    Wuyi You
    Jingfeng Liu
    Yongyi Zeng
    BMC Cancer, 23